{"id": "1371824478913765379", "creation": 1615903417.0, "user_id": "374071770", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 14, "reply_count": 1, "like_count": 51, "quote_count": 1}}, "text": "$TNXP reports 4Q and FY 2020 financial results &amp; operational highlights, w/ expected efficacy data for its lead #COVID19 #vaccine candidate in 1Q'21 and interim results from the Phase 3 RALLY study in #fibromyalgia expected in 3Q\u201921. Full details here: https://t.co/t9mc9IONnX", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#FIBROMYALGIA"]}